NCT02028208View on ClinicalTrials.gov

Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 4, 2013

Primary Completion Date

May 24, 2016

Study Completion Date

May 24, 2016

Conditions
Contact Dermatitis
Interventions
DIAGNOSTIC_TEST

Ammoniated mercury

Metal allergen panel containing ascending doses of ammoniated mercury and a negative control.

DIAGNOSTIC_TEST

Aluminum chloride and aluminum lactate

Metal allergen panel containing ascending doses of alumium chloride, aluminum lactate and a negative control.

DIAGNOSTIC_TEST

Sodium tetrachloropalladate

Metal allergen panel containing ascending doses of sodium tetrachloropalladate and a negative control.

Trial Locations (1)

SE-205 02

Skane University Hospital Malmo, Malmo

Sponsors

Lead Sponsor

Allerderm
All Listed Sponsors
lead

Allerderm

INDUSTRY

NCT02028208 - Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study | Biotech Hunter | Biotech Hunter